Combination of white-light imaging-based and narrow-band imaging-based artificial intelligence models during colonoscopy in patients with ulcerative colitis.

Journal: Journal of Crohn's & colitis
PMID: 39888722

Abstract

BACKGROUND AND AIMS: The long-term treat-to-target (T2T) approach in ulcerative colitis (UC) aims for endoscopic remission, but variability among endoscopists and a lack of precision in relapse prediction both limit its clinical usefulness. A recently reported white-light imaging (WLI) artificial intelligence (AI) model helps standardize diagnosis, although challenges remain. Therefore, we attempted to combine a narrow-band imaging (NBI) AI model with the WLI AI model to determine whether these challenges can be overcome.

Authors

  • Takanori Kuroki
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Yasuharu Maeda
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Shin-Ei Kudo
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama, 224-8503, Japan.
  • Noriyuki Ogata
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Kaoru Takabayashi
    Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
  • Kento Takenaka
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Jiro Kawashima
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan.
  • Yurie Kawabata
    Digestive Disease Center, Showa Medical University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan.
  • Shunto Iwasaki
    Digestive Disease Center, Showa Medical University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan.
  • Osamu Shiina
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Yuriko Morita
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Yuta Kouyama
    Digestive Disease Center, Showa University, Northern Yokohama Hospital, Yokohama, Japan.
  • Tatsuya Sakurai
    Digestive Disease Center, Showa Medical University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan.
  • Yushi Ogawa
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Toshiyuki Baba
    Digestive Disease Center, Showa University, Northern Yokohama Hospital, Yokohama, Japan.
  • Yuichi Mori
    Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, and Department of Transplantation Medicine Oslo University Hospital, Oslo, Norway; Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan. Electronic address: ibusiginjp@gmail.com.
  • Marietta Iacucci
    National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK.
  • Haruhiko Ogata
    Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
  • Kazuo Ohtsuka
    Tokyo Medical and Dental University, Tokyo, Japan (K.O.).
  • Masashi Misawa
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama, 224-8503, Japan.

Keywords

External Resources

Popular Topics
Recent Journals